Differential regulation of SOCS‐1 signalling in B and T lymphocytes by hepatitis C virus core protein
Open Access
- 5 September 2008
- journal article
- research article
- Published by Wiley in Immunology
- Vol. 125 (2) , 197-207
Abstract
Summary: Hepatitis C virus (HCV) infection is characterized by a strong propensity toward chronicity, autoimmune phenomena and lymphomagenesis, supporting a role for lymphocyte dysregulation during persistent viral infection. We have shown that HCV core protein inhibits T‐cell functions through interaction with a complement receptor, gC1qR. Here, we further report that B cells also express gC1qR that can be bound by HCV core protein. Importantly, using flow cytometry, we demonstrated differential regulation of B and T lymphocytes by the HCV core–gC1qR interaction, with down‐regulation of CD69 activation in T cells but up‐regulation of CD69 activation and cell proliferation in B cells. HCV core treatment led to decreased interferon‐γ production in CD8+ T cells but to increased immunoglobulin M and immunoglobulin G production as well as cell surface expression of costimulatory and chemokine receptors, including CD86 (B7‐2), CD154 (CD40L) and CD195 (CCR5), in CD20+ B cells. Finally, we showed down‐regulation of suppressor of cytokine signalling‐1 (SOCS‐1) using real‐time reverse transcription–polymerase chain reaction, accompanied by up‐regulation of signal transducer and activator of transcription‐1 (STAT1) phosphorylation in B cells in response to HCV core protein, with the opposite pattern observed in HCV core‐treated T cells. This study demonstrates differential regulation of B and T lymphocytes by HCV core and supports a mechanism by which lymphocyte dysregulation occurs in the course of persistent HCV infection.Keywords
This publication has 41 references indexed in Scilit:
- Effects of Combined Antiviral Therapy on Asymptomatic Mixed Cryoglobulinemia in Naive Patients with Chronic Hepatitis C Virus Infection: A Preliminary StudyDigestive Diseases and Sciences, 2005
- Suppressor of cytokine signaling-1 expression by infectivity-enhanced adenoviral vector inhibits IL-6-dependent proliferation of multiple myeloma cellsCancer Gene Therapy, 2005
- Treatment with peg-interferon alfa-2b and ribavirin of hepatitis C virus-associated mixed cryoglobulinemia: a pilot studyJournal of Hepatology, 2005
- The molecular basis of HCV-mediated immune dysregulationClinical Immunology, 2004
- IFN‐α antagonistic activity of HCV core protein involves induction of suppressor of cytokine signaling‐3The FASEB Journal, 2003
- Hepatitis C Virus: Immunosuppression by Complement Regulatory PathwayViral Immunology, 2001
- Hepatitis C virus core protein: intriguing properties and functional relevanceFEMS Microbiology Letters, 2001
- Hepatitis C virus infection, mixed cryoglobulinemia, and B-cell non-Hodgkin's lymphomaHepatology, 1999
- Hepatitis C virus infection and type II cryoglobulinemia: An immunological perspectiveHepatology, 1997
- Hepatitis C virus infection and type II cryoglobulinemia: An immunological perspectiveHepatology, 1997